Infections caused by Chlamydia trachomatis (including lymphogranuloma venereum) and Mycoplasma genitalium.

[1]  G. Cilla,et al.  Is the vertical transmission of Chlamydia trachomatis a little known problem in Spain? , 2019, Anales de Pediatría (English Edition).

[2]  Gustavo Cilla,et al.  Guided antibiotic therapy for Mycoplasma genitalium infections: Analysis of mutations associated with resistance to macrolides and fluoroquinolones. , 2019, Enfermedades infecciosas y microbiologia clinica.

[3]  Gustavo Cilla,et al.  ¿Es la transmisión vertical de Chlamydia trachomatis un problema poco reconocido en España? , 2019, Anales de Pediatría.

[4]  G. Cilla,et al.  Guided antibiotic therapy for Mycoplasma genitalium infections: Analysis of mutations associated with resistance to macrolides and fluoroquinolones , 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

[5]  J. Klausner,et al.  No benefit of chlamydia screening in primary care? , 2018, The Lancet.

[6]  G. Cilla,et al.  Chlamydia trachomatis genotypes A and B from urogenital specimens of patients in Spain: molecular characterization. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  M. Cole,et al.  Chlamydia trachomatis in Cervical Lymph Node of Man with Lymphogranuloma Venereum, Croatia, 2014 , 2018, Emerging infectious diseases.

[8]  P. White,et al.  Syndromic management of STIs and the threat of untreatable Mycoplasma genitalium. , 2018, The Lancet. Infectious diseases.

[9]  A. Westfall,et al.  High Prevalence of Multidrug-Resistant Mycoplasma genitalium in Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Alabama , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  R. Simons,et al.  Observed Treatment Responses to Short-Course Doxycycline Therapy for Rectal Lymphogranuloma Venereum in Men Who Have Sex With Men , 2017, Sexually transmitted diseases.

[11]  E. Harding-Esch,et al.  Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees , 2017, BMJ Open.

[12]  J. G. Kusters,et al.  Mycoplasma genitalium in Spain: prevalence of genital infection and frequency of resistance to macrolides. , 2017, Enfermedades infecciosas y microbiologia clinica.

[13]  C. Mercer,et al.  Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model , 2017, Scientific Reports.

[14]  J. Jensen,et al.  Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013–2014 Cohort of Patients in Barcelona, Spain , 2017, Sexually transmitted diseases.

[15]  M. Golden,et al.  Developing a Public Health Response to Mycoplasma genitalium , 2017, The Journal of infectious diseases.

[16]  C. Bébéar,et al.  Changing Pattern of Chlamydia trachomatis Strains in Lymphogranuloma Venereum Outbreak, France, 2010–2015 , 2016, Emerging infectious diseases.

[17]  M. Cusini,et al.  2016 European guideline on Mycoplasma genitalium infections , 2016, Journal of the European Academy of Dermatology and Venereology.

[18]  S. Garland,et al.  Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology , 2016, PloS one.

[19]  C. Bébéar,et al.  The L2b real-time PCR targeting the pmpH gene of Chlamydia trachomatis used for the diagnosis of lymphogranuloma venereum is not specific to L2b strains. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  J. Hocking,et al.  Higher organism load associated with failure of azithromycin to treat rectal chlamydia , 2016, Epidemiology and Infection.

[21]  G. Cilla,et al.  Prevalence of Chlamydia trachomatis infection in parturient women in Gipuzkoa, Northern Spain , 2016, SpringerPlus.

[22]  W. I. van der Meijden,et al.  2016 European guideline on the management of non-gonococcal urethritis , 2016, International journal of STD & AIDS.

[23]  S. Garland,et al.  The contribution of Mycoplasma genitalium to the aetiology of sexually acquired infectious proctitis in men who have sex with men. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[24]  M. Price,et al.  The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. , 2016, Health technology assessment.

[25]  P. Kerndt,et al.  Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection. , 2015, The New England journal of medicine.

[26]  Yong Jiang,et al.  Differences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant Chlamydia trachomatis isolates. , 2015, Experimental and therapeutic medicine.

[27]  K. Workowski,et al.  Sexually transmitted diseases treatment guidelines, 2015. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[28]  K. Workowski,et al.  Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  G. Cilla,et al.  Minimum spread of the new Swedish variant of Chlamydia trachomatis and distribution of C. trachomatisompA genotypes in three geographically distant areas of Spain, 2011–2012 , 2014, Infection.

[30]  N. D. Vrieze,et al.  Lymphogranuloma venereum among men who have sex with men. An epidemiological and clinical review. , 2014 .

[31]  R. Cantón,et al.  Clinical and epidemiological characterization of a lymphogranuloma venereum outbreak in Madrid, Spain: co-circulation of two variants. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[32]  B. Herrmann,et al.  Bubonic lymphogranuloma venereum with multidrug treatment failure , 2014, International journal of STD & AIDS.

[33]  F. Vazquez,et al.  Prevalence of genital Chlamydia trachomatis infection among young men and women in Spain , 2013, BMC Infectious Diseases.

[34]  D. De Angelis,et al.  Risk of Pelvic Inflammatory Disease Following Chlamydia trachomatis Infection: Analysis of Prospective Studies With a Multistate Model , 2013, American journal of epidemiology.

[35]  A. Keshavarzian,et al.  Lymphogranuloma venereum proctosigmoiditis is a mimicker of inflammatory bowel disease. , 2012, World journal of gastroenterology.

[36]  J. Paavonen.  Chlamydia trachomatis infections of the female genital tract: State of the art , 2012, Annals of medicine.

[37]  D. Taylor-Robinson,et al.  Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly , 2011, Clinical Microbiology Reviews.

[38]  H. Vardhan,et al.  Decreased Susceptibility to Azithromycin and Doxycycline in Clinical Isolates of Chlamydia trachomatis Obtained from Recurrently Infected Female Patients in India , 2010, Chemotherapy.

[39]  D. Rockey,et al.  Antibiotic resistance in Chlamydiae. , 2010, Future microbiology.

[40]  V. Smelov,et al.  Delayed microbial cure of lymphogranuloma venereum proctitis with doxycycline treatment. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  T. Quinn,et al.  Cost-Effectiveness of Screening Strategies for Chlamydia trachomatis Using Cervical Swabs, Urine, and Self-Obtained Vaginal Swabs in a Sexually Transmitted Disease Clinic Setting , 2008, Sexually transmitted diseases.

[42]  Catherine A McLean,et al.  Treatment of lymphogranuloma venereum. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  W. Edmunds,et al.  Modelling the effectiveness of chlamydia screening in England , 2006, Sexually Transmitted Infections.

[44]  S. Morré,et al.  Real-time Polymerase Chain Reaction To Diagnose Lymphogranuloma Venereum , 2005, Emerging infectious diseases.

[45]  V. Govorun,et al.  Mutations in a 23S rRNA Gene of Chlamydia trachomatis Associated with Resistance to Macrolides , 2004, Antimicrobial Agents and Chemotherapy.

[46]  J. Papp,et al.  Lymphogranuloma venereum among men who have sex with men--Netherlands, 2003-2004. , 2004, MMWR. Morbidity and mortality weekly report.

[47]  W. I. van der Meijden,et al.  Unusual presentation of early lymphogranuloma venereum in an HIV-1 infected patient: effective treatment with 1 g azithromycin , 2003, Sexually transmitted infections.

[48]  Robert E. Johnson,et al.  Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections -- 2002 , 2002 .

[49]  Michael H. Boyle,et al.  Guidelines for evaluating prevalence studies , 1998 .

[50]  T. C. Quinn,et al.  Chlamydia trachomatis proctitis. , 1981, The New England journal of medicine.

[51]  J. Parks,et al.  Lymphogranuloma venereum. , 1947, American practitioner and digest of treatment.